Position in SRPT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$5,702,382
+$5,081,186 QoQ
Shares Held
262,058
+807.8% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Jun 30, 2025CallValue
$940,500
CallShares
55,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAR1 Capital Management, LLC holds $1,363,006,285 across 212 Biotechnology names. SRPT ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,394,019 | $155,224,015 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
994,119 | $104,780,142 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,285,906 | $91,019,596 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,679,010 | $66,546,608 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
914,699 | $48,222,931 | |
| 6 | CYTK |
Cytokinetics Inc
|
632,556 | $41,691,765 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,139,331 | $41,380,501 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
1,871,455 | $35,931,936 |
All Filings in SRPT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,702,382 | 262,058 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $621,196 | 28,866 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,740,780 | 349,807 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $940,500 | 55,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $3,596,352 | 210,313 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,844,818 | 122,921 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,863,843 | 40,002 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $886,719 | 7,100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $703,100 | 4,450 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $155,352 | 1,200 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $4,026,853 | 31,105 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $777,418 | 8,062 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||